Mr. Mika has definitely had a very diverse history.
A proven chief executive and incisive board member with a consistent record of success in taking on complex strategic challenges in science & technology-based businesses, both private and public. Most recently, leading the complete restructuring and extreme transformation of a NASDAQ-traded public company from semiconductor capital equipment manufacturer to medical data analytics leader. Success required fast and aggressive operating reflexes, deep experience in restructurings, public and private financings, mergers & acquisitions, and complex, multi-year intellectual property litigation. The focus and teamwork also essential to that success were animated by a highly communicative leadership style marked by tenacity, realism, and integrity.
Executive Chairman
Rennova Health, Inc. (RNVA)
October 2015 – Present (1 year 1 month)West Palm Beach, Florida Area
Rennova Health, Inc. (NASDAQ: RNVA) is a vertically integrated Public Company that provides industry leading Diagnostics and supportive software solutions to healthcare providers. Rennova recognizes that modern healthcare requires a combination of technology and diagnostics to deliver an efficient and effective patient experience and superior clinical outcome. Rennova will continue bringing innovation to healthcare providers and deliver a single source solution through an ever-expanding group of strategic brands that work in unison to empower customers and drive growth. CollabRx, Inc. is a wholly-owned subsidiary of Rennova Health, Inc.
Executive Chairman
Sequel Power, LLC
January 2011 – March 2013 (2 years 3 months)Pleasanton, CA
Sequel Power promoted, developed and managed major solar energy projects in the U.S. and abroad, particularly in South America and Saudi Arabia.
PETALUMA, Calif., January 20, 2011 — Tegal Corporation, (Nasdaq: TGAL) today announced that it has formed, along with se2quel Partners LLC, a new company dedicated to the development and operation of large scale photovoltaic (PV)-based solar utilities in the United States, Latin America, the Middle East and Africa.
President & CEO
Tegal Corporation
March 2005 – July 2012 (7 years 5 months)Petaluma, CA
Tegal Corporation was a pioneer in the semiconductor capital equipment industry. Founded in 1972 and acquired by Motorola in 1978, the company was spun-out as an independent company in 1990, and went public on the NASDAQ in 1995. Throughout the 1990's and 2000's the industry became increasingly concentrated, with semiconductor companies relying on capital equipment suppliers for most of their product and process development. Although recognized as an innovative company with enabling technology, Tegal was competitively disadvantaged in a market that placed a high value on size and scale. Several acquisitions in the early 2000's were made to increase Tegal's scale and diversify its product-lines. Taking over as CEO in 2005, Mika terminated several of these acquisitions, restructured operations and acquired a division of Alcatel-Lucent, eventually almost tripling the company's revenue and turning it profitable in 2007. Ultimately, however, these efforts succumbed to the financial crisis in 2008/09. The Board made the decision to divest the company of its product and intellectual property assets and to pursue emerging technologies in other fields. In 2012, Tegal acquired CollabRx, Inc., a private company, changed its name to CollabRx, Inc. in September 2012, and adopted the mission and goals of CollabRx in the health care / bioinformatics industries.
Here is an old filing from Tegal
About Tegal Corporation
Tegal is an innovator of specialized production solutions for the fabrication of advanced MEMS, power ICs and optoelectronic devices found in products like smart phones, networking gear, solid-state lighting, and digital imaging. The company’s plasma etch tools enable sophisticated manufacturing techniques, such as 3D interconnect structures formed by intricate silicon etch, also known as Deep Reactive Ion Etching (DRIE). Tegal combines proven expertise with practical system strategies to deliver application-specific solutions that are robust and reliable, and deliver exceptional process quality and high yields at a lower overall cost of ownership. Headquartered in Petaluma, California, the company has more than 35 years of expertise and innovation in specialized technologies, over 100 patents, and an installed base of more than 1900 systems worldwide. Please visit us on the web at www.Tegal.com.
Executive Vice President & CFO
Tegal Corporation
July 2002 – March 2005 (2 years 9 months)Petaluma, CA
Founding Partner
International Management Technology Corp. (IMTEC)
1982 – 2002 (20 years)Stamford, CT
IMTEC was a boutique investment firm that operated from 1982 until the early 2000's. We concluded multiple private equity financings, joint ventures, acquisitions and license agreements on behalf of clients in the health care, pharmaceuticals, media and information technology industries. In addition, when required, we took top management positions in companies in which we founded or invested, including DISC International, Inc. (a software company) and Soupmasters International, Inc. (a chain of quick-service mall-based restaurants).
Interesting piece history from a 1996 filing for Tegal Corporation.
Thomas R. Mika has served as a director of the Company since June 1992.
Since January 1982, he has been a Vice President of International Management and Technology Corporation ("IMTEC"), a consulting and investment banking firm that specializes in facilitating strategic alliances between U.S. and Japanese technology-based companies.
Rennova Health, Inc. (NASDAQ:RNVA), (NASDAQ:RNVAZ), a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers, announced today that on September 13, 2016, Nasdaq confirmed that the Company had been granted an extension of 180 days to comply with rule 5550(a)(2) (“the Rule”), relating to the bid price of the Company’s common stock not meeting the minimum $1.00 per share requirement for continued listing.
